Items where Author is "Moschos, Sterghios"

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 94.

Article

Kumar, Manish and Moschos, Sterghios (2017) Oligonucleotide therapies for the lung: ready to return to the clinic? Molecular Therapy. ISSN 1525-0016 (In Press)

Shah, Kavit, Bentley, Emma, Tyler, Adam, Richards, Kevin, Wright, Edward, Easterbrook, Linda, Lee, Diane, Cleaver, Claire, Usher, Louise, Burton, Jane, Pitman, James, Bruce, Christine, Norwood, David and Moschos, Sterghios (2017) Field-deployable, Quantitative, Rapid Identification of Active Ebola Virus Infection in Unprocessed Blood. Chemical Science, 8. pp. 7780-7797. ISSN 2041-6539

Theotokis, Pantazis, Usher, Louise, Kortschak, Christopher K., Schwalbe, Ed and Moschos, Sterghios (2017) Profiling the Mismatch Tolerance of Argonaute 2 through Deep Sequencing of Sliced Polymorphic Viral RNAs. Molecular Therapy - Nucleic Acids. ISSN 2162-2531

Esmaeilishirazifard, Elham, De Vizio, Daniela, Moschos, Sterghios and Keshavarz, Tajali (2017) Genomic and molecular characterization of a novel quorum sensing molecule in Bacillus licheniformis. AMB Express, 7 (78). ISSN 2191-0855

Moschos, Sterghios, Usher, Louise and Lindsay, Mark (2017) Clinical potential of oligonucleotide-based therapeutics in the respiratory system. Pharmacology & Therapeutics, 169. pp. 83-103. ISSN 0163-7258

Usher, Louise, Kortschak, Christopher K. and Moschos, Sterghios (2016) Transitioning a gene therapy mechanism of action confirmation assay from the bench to the bedside. Human Gene Therapy, 27 (7). A13-A14. ISSN 1043-0342

Moschos, Sterghios (2015) Introducing EbolaCheck: potential for point-of-need infectious disease diagnosis. Expert Review of Molecular Diagnostics, 15 (10). pp. 1237-40. ISSN 1744-8352

Denise, Hubert, Moschos, Sterghios, Sidders, Benjamin, Burden, Frances, Perkins, Hannah, Carter, Nikki, Stroud, Tim, Kennedy, Michael, Fancy, Sally-Ann, Lapthorn, Cris, Lavender, Helen, Kinloch, Ross, Suhy, David and Corbau, Romu (2014) Deep sequencing insights in therapeutic shRNA processing and siRNA target cleavage precision. Molecular Therapy - Nucleic Acids, 3. e145. ISSN 2162-2531

Moschos, Sterghios (2012) Genomic biomarkers for patient selection and stratification: the cancer paradigm. Bioanalysis, 4 (20). pp. 2499-511. ISSN 1757-6180

Suhy, David, Kao, Shih-Chu, Mao, Tin, Whiteley, Laurence, Denise, Hubert, Souberbielle, Bernard, Burdick, Andrew, Hayes, Kyle, Wright, J. Fraser, Lavender, Helen, Roelvink, Peter, Kolykhalov, Alexander, Brady, Kevin, Moschos, Sterghios, Hauck, Bernd, Zelenaia, Olga, Zhou, Shangzhen, Scribner, Curt, High, Katherine, Renison, Sara and Corbau, Romu (2012) Safe, long-term hepatic expression of anti-HCV shRNA in a nonhuman primate model. Molecular therapy : the journal of the American Society of Gene Therapy, 20 (9). pp. 1737-49. ISSN 1525-0024

Cucurull-Sanchez, Lourdes, Spink, Karen and Moschos, Sterghios (2012) Relevance of systems pharmacology in drug discovery. Drug Discovery Today, 17 (13-14). pp. 665-670. ISSN 1359-6446

Moschos, Sterghios (2012) In vivo Pharmacology: reaping the benefits of analysis at the cell type level. Pharmacology Matters, 5 (1). pp. 15-16. ISSN 1757-8175

Tsitsiou, Eleni, Williams, Andrew Evan, Moschos, Sterghios, Patel, Ketan, Rossios, Christos, Jiang, Xiaoying, Adams, Oona-Delpuech, Macedo, Patricia, Booton, Richard, Gibeon, David, Chung, Kian Fan and Lindsay, Mark (2012) Transcriptome analysis shows activation of circulating CD8+ T cells in patients with severe asthma. Journal of Allergy and Clinical Immunology, 129 (1). pp. 95-103. ISSN 0091-6749

Moschos, Sterghios, Frick, Manfred, Taylor, Bruce, Turnpenny, Paul, Graves, Helen, Spink, Karen, Brady, Kevin, Lamb, David, Collins, David, Rockel, Thomas, Weber, Markus, Lazari, Ovadia, Perez-Tosar, Luis, Fancy, Sally-Ann, Lapthorn, Chris, Green, Martin, Evans, Steve, Selby, Matthew, Jones, Gareth, Jones, Lyn, Kearney, Sarah, Mechiche, Houria, Gikunju, Diana, Subramanian, Romesh, Uhlmann, Eugen, Jurk, Marion, Vollmer, Jörg, Ciaramella, Giuseppe and Yeadon, Michael (2011) Uptake, efficacy, and systemic distribution of naked, inhaled short interfering RNA (siRNA) and locked nucleic acid (LNA) antisense. Molecular Therapy, 19 (12). pp. 2163-2168. ISSN 1525-0016

Laxton, Carl, Brady, Kevin, Moschos, Sterghios, Turnpenny, Paul, Rawal, Jaiessh, Pryde, David, Sidders, Ben, Corbau, Romu, Pickford, Chris and Murray, E. J. (2011) Selection, optimization, and pharmacokinetic properties of a novel, potent antiviral locked nucleic acid-based antisense oligomer targeting hepatitis C virus internal ribosome entry site. Antimicrobial agents and chemotherapy, 55 (7). pp. 3105-14. ISSN 1098-6596

Brock, Graham, Moschos, Sterghios, Spivack, Simon and Hurteau, Gregory (2011) The 3 prime paradigm of the miR-200 family and other microRNAs. Epigenetics, 6 (3). pp. 268-272. ISSN 1559-2294

Williams, Andrew Evan, Perry, Mark, Moschos, Sterghios, Larner-Svensson, Hanna and Lindsay, Mark (2008) Role of miRNA-146a in the regulation of the innate immune response and cancer. Biochemical Society Transactions, 36 (6). pp. 1211-1215. ISSN 0300-5127

Perry, Mark, Moschos, Sterghios, Williams, Andrew Evan, Shepherd, Neil, Larner-Svensson, Hanna and Lindsay, Mark (2008) Rapid changes in microRNA-146a expression negatively regulate the IL-1beta-induced inflammatory response in human lung alveolar epithelial cells. The Journal of Immunology, 180 (8). pp. 5689-98. ISSN 0022-1767

Moschos, Sterghios, Spinks, Karen, Williams, Andrew Evan and Lindsay, Mark (2008) Targeting the lung using siRNA and antisense based oligonucleotides. Current Pharmaceutical Design, 14 (34). pp. 3620-3627. ISSN 1381-6128

Moschos, Sterghios, Jones, Simon Wyn, Perry, Mark, Williams, Andrew Evan, Erjefalt, Jonas, Turner, John James, Barnes, Peter John, Sproat, Brian, Gait, Michael and Lindsay, Mark (2007) Lung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity. Bioconjugate chemistry, 18 (5). pp. 1450-9. ISSN 1043-1802

Moschos, Sterghios, Williams, Andrew Evan and Lindsay, Mark (2007) Cell-penetrating-peptide-mediated siRNA lung delivery. Biochemical Society Transactions, 35 (4). pp. 807-810. ISSN 0300-5127

Moschos, Sterghios, Williams, Andrew Evan, Perry, Mark, Birrell, Mark, Belvisi, Maria and Lindsay, Mark (2007) Expression profiling in vivo demonstrates rapid changes in lung microRNA levels following lipopolysaccharide-induced inflammation but not in the anti-inflammatory action of glucocorticoids. BMC Genomics, 8. p. 240. ISSN 1471-2164

Williams, Andrew Evan, Perry, Mark, Moschos, Sterghios and Lindsay, Mark Andrew (2007) microRNA expression in the aging mouse lung. BMC Genomics, 8. p. 172. ISSN 1471-2164

Williams, Andrew Evan, Moschos, Sterghios, Perry, Mark, Barnes, Peter John and Lindsay, Mark (2007) Maternally imprinted microRNAs are differentially expressed during mouse and human lung development. Developmental Dynamics, 236 (2). pp. 572-80. ISSN 1058-8388

Turner, John James, Jones, Simon Wyn, Moschos, Sterghios, Lindsay, Mark and Gait, Michael (2007) MALDI-TOF mass spectral analysis of siRNA degradation in serum confirms an RNAse A-like activity. Molecular bioSystems, 3 (1). pp. 43-50. ISSN 1742-206X

Moschos, Sterghios, Bramwell, Vincent, Somavarapu, Satyanarayna and Alpar, H. Oya (2006) Modulating the adjuvanticity of alum by co-administration of muramyl di-peptide (MDP) or Quil-A. Vaccine, 24 (8). pp. 1081-1086. ISSN 0264-410X

Moschos, Sterghios, Bramwell, Vincent, Somavarapu, Satyanarayna and Alpar, H. Oya (2005) Comparative immunomodulatory properties of a chitosan-MDP adjuvant combination following intranasal or intramuscular immunisation. Vaccine, 23 (16). pp. 1923-30. ISSN 0264-410X

Moschos, Sterghios, Bramwell, Vincent, Somavarapu, Satyanarayna and Alpar, H. Oya (2004) Adjuvant synergy: the effects of nasal coadministration of adjuvants. Immunology and Cell Biology, 82 (6). pp. 628-37. ISSN 0818-9641

Moschos, Sterghios, Somavarapu, S., Bramwell, Vincent, Randall, L., Guy, B. and Alpar, Oya (2001) Evaluation of adjuvanted recombinant urease foreffective immunization againstHelicobacter pylori. Immunology, 104 (S1). p. 98. ISSN 1365-2567

Moschos, Sterghios, Somavarapu, S., Bramwell, Vincent, Randall, L., Guy, B. and Alpar, Oya (2001) Quil-A and MDP enhances the adjuvanticity of alum for intramuscular delivery of rURE. Immunology, 104 (S1). p. 98. ISSN 1365-2567

Book Section

Moschos, Sterghios (2013) MicroRNA Biotherapeutics: Key Challenges from a Drug Development Perspective. In: Biotherapeutics: Recent Developments using Chemical and Molecular Biology. RSC, pp. 176-223. ISBN 978-1-84973-601-5

Moschos, Sterghios, Spink, Karen and Lindsay, Mark (2011) Measuring the action of CPP-siRNA conjugates in the lung. In: Cell-Penetrating Peptides : Methods and Protocols. Methods in Molecular Biology, 683 . Springer, London, pp. 417-429. ISBN 9781607619185

Moschos, Sterghios, Williams, Andrew E. and Lindsay, Mark A. (2006) In Vivo Applications of Cell-Penetrating Peptides. In: Handbook of Cell-Penetrating Peptides. Taylor & Francis, London, pp. 423-438. ISBN 9780849350900

Conference or Workshop Item

Moschos, Sterghios (2017) Bedside NGS diagnostics for the oligonucleotide therapeutics market: from patient selection to drug efficacy quantification. In: Molecular Diagnostics World Summit 2017, 12th - 13th July 2017, London.

Moschos, Sterghios (2017) RNA therapeutics for lung disease. In: Institute of Cellular Medicine, March 2017, Newcastle University.

Moschos, Sterghios (2017) BreatheIN: Realising the Clinical Potential of Oligonucleotide Rx for Respiratory Disease. In: Seminar- Research Centre Borstel - Leibniz Center for Medicine and Bioscience, February 2017, Borstel, Germany.

Moschos, Sterghios (2017) BreatheIN: Realising the Clinical Potential of Oligonucleotide Rx for Respiratory Disease. In: MedImmune & AstraZeneca joint presentation, February 2017, Cambridge.

Moschos, Sterghios and Maltezou, Helen (2016) Making a Difference: Leveraging Innovation to Meet Clinical Need. In: 2nd Congress of Pharmacogenomics and Personalised Diagnostics and Therapy, 4-6 November 2016, Athens.

Moschos, Sterghios (2016) SEQing Drug Activity – from the Bench to the Bedside. In: 2nd Congress of Pharmacogenomics and Personalised Diagnostics and Therapy, 4-6 November 2016, Athens.

Shah, Kavit, Bentley, Emma, Usher, Louise, Ozuna, Alina, Tyler, Adam, Richards, Kevin, Edge, David, Right, Edward, Lee, Martin, Nazareth, Nelson, Norwood, David and Moschos, Sterghios (2016) Direct Bedside Quantification of DNA and RNA in Crude, Whole Biofluids. In: 12th Annual Meeting of the Oligonucleotide Therapeutics Society, 25-28 September 2016, Montreal.

Usher, Louise and Moschos, Sterghios (2016) RACE-seq(ing) Argonaute-2 cleavage precision. In: 12th Annual Meeting of the Oligonucleotide Therapeutics Society, 25-28 September 2016, Montreal.

Moschos, Sterghios (2016) EbolaCheck: Point of Care qPCR matches lab-based clinical diagnostic laboratory Ebolavirus detection sensitivity. In: Molecular Diagnostics World Summit, 19-20 May 2016, London.

Shah, Kavit, Richards, Kevin, Bruce, C., Vipond, R., Easterbrook, L., Opoku-Okrah, C., Debrah, A.-Y., Wright, E., Carrol, M., Norwood, David and Moschos, Sterghios (2016) EbolaCheck: Realising Point of Care Molecular Diagnostics at the Point of Need. In: International Society for Neglected & Tropical Diseases d3: Diagnostics, Drug Discovery & Development, 25-26 May 2016, London.

Moschos, Sterghios (2016) Resolving Molecular Diagnostics Need for Ebola, Advancing Point of Care Testing for the West. In: 2nd Advanced Diagnostics for Infectious Disease Conference, 5-6 April 2016, Lisbon.

Moschos, Sterghios (2016) Molecular Diagnostics at the Point of Care: Ebola and Beyond. In: The 2016 Molecular Medicine Tri-Conference, 6-11 March 2016, San Francisco.

Moschos, Sterghios (2016) Ebolacheck: Delivering Molecular Diagnostics at the Point of Need. In: National Infection Service and Public Health England’s Infectious Diseases Research Workshop, February 2016, London.

Moschos, Sterghios (2015) Ebola Check: Delivering molecular diagnostics at the point of need. In: 3rd International Medical Olympaid, 2 - 4 October 2015, Thessaloniki.

Moschos, Sterghios (2015) Molecular Diagnostics & Next Gen Sequencing: Choosing the right tools for the right task. In: 7th Annual Next Generation Sequencing & 3rd Annual Single Cell Analysis Congress, November 2015, London.

Moschos, Sterghios (2015) From Molecular Biomarkers to Point of Care Molecular Diagnostics: Lessons from Ebola, Opportunities Beyond. In: GTC Bio’s 4th Biomarkers in Diagnostics Conference, October 2015, Berlin.

Moschos, Sterghios (2015) Molecular diagnostics at the bedside, electricity or not: From Ebola to NGS. In: Emerging Viruses 2015, 27-29 July 2015, Nottingham.

Moschos, Sterghios (2015) EbolaCheck - the first true POC qRT-PCR device for 3rd world humanitarian crisis responses. In: Biodefense World Summit, 22-26 June 2015, Bethesda.

Moschos, Sterghios (2015) Overcoming the challenges of biomarker adoption in clinical trials for rare disease treatment. In: Biomarkers World Europe, 2-3 June 2015, London.

Fraszczak, M., Usher, Louise, Frick, Manfred, Lennerz, Jochen and Moschos, Sterghios (2015) A common brain microbiome in normal rodents & humans: evidence on entry routes with an intact blood-brain-barrier. In: 6th Congress of European Microbiologists (FEMS 2015), 7-11 June 2015, Maastricht.

Kremyda-Vlachou, Myrto, Esmaeilishirazifard, Elham, Usher, Louise, Trim, S. and Moschos, Sterghios (2015) The microbiome of venoms. In: 6th Congress of European Microbiologists (FEMS 2015), 7-11 June 2015, Maastricht.

Shah, Kavit and Moschos, Sterghios (2015) EbolaCheck: Realising point of care molecular diagnostics. In: 3rd International Congress on Targeting Infectious Diseases: Targeting Ebola, 28-29 May 2015, Paris.

Moschos, Sterghios (2015) Progress update on EbolaCheck. In: International Society for Neglected & Tropical Diseases d3: Diagnostics, Drug Discovery & Development, 20-21 May 2015, London.

Moschos, Sterghios (2015) CL2/4 Validation Strategy for EbolaCheck, a whole blood POC NAT MDx system. In: Technical Workshop on the Standardisation of Serological & PCR Assays for the Detection of EbolaVirus, March 2015, Potters Bar.

Moschos, Sterghios (2015) Seq-ing drug activity: from the bench to the bedside. In: RNA-Seq Europe 2015, 20-22 January 2015, London.

Eminaga, Yaprak, Coskun, Adem, Moschos, Sterghios and Kale, Izzet (2015) Low complexity all-pass based polyphase decimation filters for ECG monitoring. In: 11th Conference on Ph.D. Research in Microelectronics and Electronics (PRIME), 29 June- 2 July 2015, Glasgow.

Moschos, Sterghios (2014) What can NGS offer to the cancer pathologist? In: The 2014 Pathology Congress, 2-4 December 2014, London.

Taylor, J. D., Esmaeilishirazifard, Elham, Moschos, Sterghios, Percy, L. and Lewis, J. (2014) Whole community profiling of harmful algae; sequencing 18S rRNA amplicons on an Ion torrent PGM. In: 16th International Conference on Harmful Algae, 27-31 October 2014, Wellington.

Moschos, Sterghios (2014) Personalised medicine drug discovery & companion diagnostic development: an NGS how to. In: Biomarker Utilisation & Commercialisation Conference, 10-11 September 2014, London.

Wilkinson, A., Usher, Louise, MacKenzie, R., Kale, Izzet and Moschos, Sterghios (2014) Pulmoscreen: towards the first autonomous respiratory microbiome biosensor. In: Sensors in Medicine 2014, 25-26 March 2014, London.

Moschos, Sterghios (2014) Oligonucleotide chemistry: bio-distribution, targeting & uptake challenges. In: 6th AsiaTIDES - Oligonucleotide & Peptide Research, Technology & Product Development, 25-27 February 2014, Tokyo.

Moschos, Sterghios (2014) Seq-ing RNAi: Bioprocesing of shRNA & siRNA mode of action. In: 6th AsiaTIDES - Oligonucleotide & Peptide Research, Technology & Product Development, 25-27 February 2014, Tokyo.

Esmaeilishirazifard, Elham, Moschos, Sterghios and Keshavarz, Tajalli (2014) Inter-kingdom cross-talk & its bio-control applications. In: IUMS 2014, 27 July- 1 August 2014, Montreal.

Moschos, Sterghios (2013) Sequencing Cancer – Next Generation Sequencing in Clinical Practice. In: Issues With Tissues Meeting, 19 October 2013, London.

Taylor, J. and Moschos, Sterghios (2013) Genomic biomarker discovery in personalised medicine: Westminster Genomic Services. In: 8th Annual Biomarkers Congress, 19-20 February 2013, Manchester.

Moschos, Sterghios (2012) Local & Systemic Action of Oligonucleotides Dosed to the Lung. In: Oligonucleotide Delivery: Biology, Engineering & Development, October 2012, Vienna.

Moschos, Sterghios (2012) NGS revelations in shRNA maturation & siRNA mode of action mechanisms. In: Next Generation Sequencing Conference, 17-18 September 2012, London.

Taylor, J. and Moschos, Sterghios (2012) Insights in shRNA Processing & siRNA Mode of Action Using Next Generation Sequencing. In: UK Next Gen Sequencing Meeting, 28-30 August 2012, Nottingham.

Moschos, Sterghios (2012) Topical Dosing of siRNA & LNA Antisense to the Lung: The Liver is the Target. In: RNAi, MiRNA SiRNA: A Focus On Nanotechnology Delivery Conference, 11-12 June 2012, London.

Moschos, Sterghios (2012) 3rd generation sequencing applications in clinical research & beyond. In: What can DNA do for you? DNA technologies and applications, 3 May 2012, London.

Moschos, Sterghios (2012) Oligonucleotide inhalation: the liver is the target. In: RNAi2012: Gene Regulation by Small RNAs, 7th International Conference and Exhibition, 27-29 March 2012, Oxford.

Moschos, Sterghios (2011) Challenges & opportunities in oligonucleotide therapeutics inhalation. In: 12th Annual EuroTIDES Conference, 15-16 November 2011, Berlin.

Moschos, Sterghios (2011) Nil by Needle: siRNA & LNA antisense inhalation studies reveal opportunities in non-invasive, systemic administration. In: 2nd RNAi Research & Therapeutics Conference, 7-8 July 2011, San Francisco.

Moschos, Sterghios (2011) Inhalation of siRNA & LNA antisense: Liver targeting is a distinct possibility. In: The Future of Drug Delivery Systems: Advancing New Technologies & Partnering Strategies, 24-25 May 2011, London.

Graves, H., Taylor, B., Mechiche, J. and Moschos, Sterghios (2010) Flow cytometric identification of cell types in digested mouse lung. In: 9th Annual Symposium on Biopharmaceuticals: San Diego Bio-Pharma Conference, 5 June 2010, San Diego.

Moschos, Sterghios (2010) microRNA as biomarkers: challenges & opportunities. In: 6th Annual microRNA in Human Disease & Development Conference, 22-24 March 2010, Boston.

Moschos, Sterghios (2010) microRNAs as biomarkers of disease & drug efficacy. In: 5th Annual Biomarkers Congress, 25-26 February 2010, Manchester.

Moschos, Sterghios (2009) Oligonucleotides-based approaches. In: British Association of Lung Research Summer Meeting, July 2009, Manchester.

Moschos, Sterghios (2009) Use of microRNA as biomarkers. In: 4th RNAi, siRNA & miRNA Conference, 18-19 March 2009, Oxford.

Moschos, Sterghios (2008) siRNA solutions for biodefence of the lung. In: Applications of antiviral RNA interference (RNAi), 5-10 April 2008, Sant Feliu de Guixols.

Moschos, Sterghios (2007) Expression profiling implicates microRNA expression in the resolution of the inflammatory response in vivo. In: American Thoracic Society Annual Meeting, 18-23 May 2007, San Francisco.

Moschos, Sterghios, Perry, M., Williams, A. and Lindsay, M. (2007) Expression profiling implicates microRNA expression in the resolution of the inflammatory response in vivo. In: American Thoracic Society (ATS) 103rd International Conference, 18-23 May 2007, San Francisco.

Perry, M., Moschos, Sterghios, Williams, A. and Lindsay, M. (2007) Increased expression of microRNA-146a/b negatively regulates IL-1b induced cytokine release from airway epithelial cells. In: American Thoracic Society (ATS) 103rd International Conference, 18-23 May 2007, San Francisco.

Williams, A., Moschos, Sterghios, Perry, M. and Lindsay, M. (2007) MicroRNAs are differentially expressed in the developing lung but not in the aged lung. In: American Thoracic Society (ATS) 103rd International Conference, 18-23 May 2007, San Francisco.

Moschos, Sterghios (2005) New toys with old problems: safety & delivery issues in the therapeutic application of RNAi. In: EuroSciCon - RNA Mediated Interference in Practice, 8 April 2005, London.

Moschos, Sterghios, Pandit, Sreenivas, Somavarapu, Satyanarayna, Balaban, N. and Alpar, Oya (2004) New strategies in vaccine research: targeting quorum sensing pathways for prophylaxis against antibiotic-resistant S. aureus infections. In: 31st International Symposium for the Controlled Release of Bioactive Materials 2004, 12-16 June 2004, Honolulu.

Moschos, Sterghios, Bramwell, Vincent and Alpar, Oya (2003) Considerations in the antigen-stimulated, primed, primary splenocyte culture model as an in vitro vaccine screening tool. In: 30th International Symposium for the Controlled Release of Bioactive Materials, 19-23 July 2003, Glasgow.

Moschos, Sterghios, Somavarapu, Satyanarayna, Singh, Jasvinder, Bramwell, Vincent, Randall, L., Guy, B. and Alpar, Oya (2001) Immunogenicity of adjuvanted recombinant urease administered intranasally. In: 28th International Symposium for the Controlled Release of Bioactive Materials, 23-27 June 2001, San Diego.

Moschos, Sterghios, Somavarapu, Satyanarayna, Singh, Jasvinder, Bramwell, Vincent, Randall, L., Guy, B. and Alpar, Oya (2000) Novel protein secretion from both ex-vivo Peyers' patches and in-vivo; induction by microsphere encapsulated diphtheria toxoid. In: 27th International Symposium for the Controlled Release of Bioactive Materials, 9-13 July 2001, Paris.

Turner, John, Somavarapu, Satyanarayna, Moschos, Sterghios, Randall, L., Simpkin, G. and Alpar, Oya (2000) Microsphere encapsulated Diphtheria Toxoid induces protein secretion from in-vitro Peyers' patches and in vivo. In: 3rd World Meeting APV/APGI 2000, 3-6 April 2000, Berlin.

Patent

University of Westminster (2017) Exhaled breath condensate collection device and a kit of parts thereof. GB2548122 (A).

This list was generated on Sun Dec 10 19:55:53 2017 UTC.

Policies: NRL Policies | NRL University Deposit Policy | NRL Deposit Licence